Evidence map›Paper›PMID 36402803›Full record

ArticleScientific reports2022

Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age.

Eneritz Velasco-Arnaiz, Marta Batllori, Manuel Monsonís, Anna Valls, María Ríos-Barnes, Sílvia Simó-Nebot, Anna Gamell, Clàudia Fortuny, Marc Tebruegge, Antoni Noguera-Julian

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Immune Sensitization toPathogens (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 5 countries.

Eneritz Velasco-ArnaizMalalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria; Servei d'Infectologia Pediàtrica, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Marta BatlloriLaboratori de Bioquímica, Hospital Sant Joan de Déu, Barcelona, Spain.
Manuel MonsonísServei de Microbiologia. Hospital Sant Joan de Déu, Barcelona, Spain.
Anna VallsLaboratori de Bioquímica, Hospital Sant Joan de Déu, Barcelona, Spain.
María Ríos-BarnesMalalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria; Servei d'Infectologia Pediàtrica, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Sílvia Simó-NebotMalalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria; Servei d'Infectologia Pediàtrica, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Anna GamellMalalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria; Servei d'Infectologia Pediàtrica, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Clàudia FortunyMalalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria; Servei d'Infectologia Pediàtrica, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Marc TebrueggeDepartment of Infection, Immunity and Inflammation, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
Antoni Noguera-JulianMalalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria; Servei d'Infectologia Pediàtrica, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. ton@hsjdbcn.es.ORCID 0000-0001-7485-0583
Hospital Sant Joan de Déu Barcelona · ESRed de Investigación en Actividades Preventivas y Promoción de la Salud · ESDepartament de Salut · ESThe University of Melbourne · AU

Funding

Departament de Salut, Generalitat de Catalunya SLT008/18/00193Instituto de Salud Carlos III CM18/00054Instituto de Salud Carlos III FI20/00237
6 · The paper itself

Abstract

Interferon-gamma release assays performance can be impaired by host-related, technical and environmental factors, but data in young children are limited. We performed a cross-sectional study of children < 5 years-of-age at risk of tuberculosis (TB), using QuantiFERON-TB Gold In-Tube (QFT-GIT) assays. The impact of the following was evaluated: (i) host-related [age; hematological parameters; erythrocyte sedimentation rate (ESR); C-reactive protein (CRP); and tobacco smoke exposure (TSE) based on serum cotinine concentrations], (ii) technical (pre-analytical delay) and (iii) environmental factors (annual season; monthly temperatures). Of 204 children, 35 (17.2%) were diagnosed with latent TB infection or TB disease. QFT-GIT results were indeterminate in 14 (6.9%) patients. In multivariate analysis, younger age and higher ESR were associated with lower positive control responses (beta: 0.247, p = 0.002 and - 0.204, p = 0.007, respectively), and increasing age was associated with lower rates of indeterminate QFT-GIT results [OR (95% CI) 0.948 (0.903-0.996) per month, p = 0.035]. In children with positive QFT-GIT results, average monthly temperatures correlated with antigen responses (r = 0.453, p = 0.020); also, antigen responses were lower in winter than in other seasons (p = 0.027). Serum cotinine concentrations determined in a subgroup of patients (n = 41) indicated TSE in 36 (88%), positive control responses being lower in children with TSE (p = 0.034). In children < 5 years-of-age, young age, elevated ESR, temperature, annual season and TSE can affect the performance of QFT-GIT assays.

Indexed as

Latent TuberculosisTuberculosisAcute-Phase ReactionChildChild, PreschoolCotinineCross-Sectional StudiesHumansInterferon-gamma Release TestsCotinine

Identifiers

PMID36402803
PMCPMC9675832
OpenAlexW4309563008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.